แจกโบบัสฟรีเกมสยิงปลา_casino ฟรี เครดิต_วิเคราะห์ บอล วัน นี้ ตลาด ลูก หนัง

The following  is a collection of companies conducting or applying epigenetics research in Alberta. The list is a work in progress and will be updated continually. If you have a resource to add to the list please contact us.

List of companies conducting or applying epigenetics research in Alberta.


Company Services Contact in Alberta Contact Phone Contact Email Website
Resverlogix Corp.  Resverlogix Corp. (TSX: RVX) is a clinical stage cardiovascular company with an epigenetic platform technology that modulates protein production. Resverlogix is developing RVX-208, a first-in-class BET bromodomain inhibitor molecule for the treatment of atherosclerosis. Donald McCaffrey 1.403.254.9252 info@resverlogix.com http://www.resverlogix.com
Zenith Epigenetics Corp. Zenith Epigenetics Corp. is a biotechnology company with a broad and deep drug discovery platform in the area of epigenetics, developing orally active, small molecules that are selective for binding and inhibition of BET bromodomains. Zenith’s lead product is a pan selective BET inhibitor being developed for hematological malignancies and solid tumors. Donald McCaffrey 1.587.390.7865 info@zenithepigenetics.com http://www.zenithepigenetics.com
Plantbiosis PlantBiosis offers full scale plant transformation service and nucleotide deep sequencing service. Igor Kovalchuk 1.403.325.2579 igor.kovalchuk@uleth.ca http://www.plantbiosis.com
Canada Cancer and Aging Research Laboratories Canada Cancer and Aging Research Laboratories (CCARL) is a research and development company offering a personalized approach to cancer treatment. Empowered by decades of knowledge on molecular signatures of various cancers, sex- and age-specificity of cancer response to treatment, molecular and biochemical characteristics of regulation of various pro- and anti-cancer pathways, CCARL has been able to generate a product that allows doctors to make case-by-case decisions as far as a patient’s treatment is concerned. Olga Kovalchuk 1.403.3292579 olga.kovalchuk@ccarl.ca http://www.ccarl.ca
ChemRoutes Corp. ChemRoutes Corp. is a private drug discovery technology provider operating at the interface of organic chemistry, chemical biology, drug discovery, and nanotechnology. They are developing a collection of 200,000 small molecules with epigenetic properties (writers/erasers) on proprietary and novel small molecule based scaffolds. Aubrey Mendonca 1.780.988.1223 aubrey@chemroutes.com http://www.chemroutes.com/

Our Partners

Alberta Government Genome Alberta University of Calgary University of Lethbridge University of Alberta